Additional $$$ Raises: #NiloTherapeutics $101M Series A; #Waat €100M; #Inspiren $100M Series B; #Einride $100M Series D; #Supabase $100M Series E

Acquisitions: #AimmerBiomet > #Monogram; #Coupe > #Scoutbee; #Clariti > #CivCheck; #Helsing > #BlueOcean; #Hyperproof > #Expent.ai

Could the brain be a target for autoimmune disease? A new biotech company Nilo Therapeutics believes the brain could hold the key to treating autoimmune diseases, with further studies to follow.

A new biotech company believes the brain could hold the key to treating immune diseases.

Headed up by CEO Dr Kim Seth, #NiloTherapeutics have earned $101m in funding to explore their hypothesis.

Discover more: www.emjreviews.com/emj-gold/new...